Dr. Jeffrey M. Liebmann graduated from Boston University School of Medicine in 1984,
completed his residency at the State University of New York/Downstate Medical Center in 1987 and his glaucoma fellowship at the New York Eye and Ear Infirmary. Dr. Liebmann is presently Clinical Professor of Ophthalmology at New York University School of Medicine and Director of Glaucoma Services at Manhattan Eye, Ear, and Throat Hospital and New York University Medical Center and Adjunct Professor of Clinical Ophthalmology at New York Medical College, Valhalla, New York. He is a fellow of the American Academy of Ophthalmology and American College of Surgeons as well as a member of numerous scientific and medical organizations including the Association for Research in Vision and Ophthalmology and the American Glaucoma Society. Dr. Liebmann serves as Program Chair for the American Glaucoma Society and Secretary-Treasurer of the New York Glaucoma Society, is a member of the Board of Governors of the World Glaucoma Association and Board of Directors of The Glaucoma Foundation, and is past-President of the New York Society for Clinical Ophthalmology and co-founder of the New York Glaucoma Research Institute.
Dr. Liebmann is currently the Principal Investigator of two National Eye Institute Clinical Trials sponsored by the National Institutes of Health, including the Ocular Hypertension Treatment Study, a nationwide glaucoma research project. Dr. Liebmann is the author and/or co-author of over 425 medical and scientific papers, book chapters, and abstracts. In addition, he has lectured widely in the United States and abroad on glaucoma diagnosis and management. His current main areas of research interest include investigations into the causes of glaucoma, glaucoma surgery, ocular imaging, and neuroprotection.